• FOLLOW US
Video Player
  • Email
  • share

AstraZeneca Heart Drug Trial No Longer Subject of a Federal Probe

AstraZeneca says the Department of Justice is ending its investigation into PLATO, a clinical trial with its heart drug Brilinta, and is not planning any further action. It began investigating the PLATO trial, which studied more than 18,000 patients

http://www.wltx.com/video/3740014777001/1/AstraZeneca-Heart-Drug-Trial-No-Longer-Subject-of-a-Federal-Probe http://cdn.newslook.com/1f/1f7a1fc9e81402c5a86f08bd30941e8a/images/frame_ext.jpg AstraZeneca Heart Drug Trial No Longer Subject of a Federal Probe AstraZeneca says the Department of Justice is ending its investigation into PLATO, a clinical trial with its heart drug Brilinta, and is not planning any further action. It began investigating the PLATO trial, which studied more than 18,000 patients FinanceAZNyoutubeYahoo!newslookPascal Soriotastrazeneca plc 00:52

Next Up

    

More Videos